| 000 | 00845 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250510211250.0 | ||
| 264 | 0 | _c19790816 | |
| 008 | 197908s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(79)91778-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNalin, D R | |
| 245 | 0 | 0 |
_aChlorpromazine and cholera. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMay 1979 |
||
| 300 |
_a988 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aCholera _xdrug therapy |
| 650 | 0 | 4 |
_aDehydration _xprevention & control |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProchlorperazine _xtherapeutic use |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8123 _gp. 988 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(79)91778-1 _zAvailable from publisher's website |
| 999 |
_c85675 _d85675 |
||